#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4438	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2474	530.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1939	1939	T	608	T	527	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4438	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2474	530.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1673	1673	C	650	C	544	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7178	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3891	552.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1840	1840	A	661	A,C,G	558,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7178	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3891	552.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2474	2474	C	636	C,A	536,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7178	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3891	552.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2548	2548	A	615	A,C	518,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7178	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3891	552.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3100	3100	C	568	C,T,A	281,191,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	802	folP	855	855	100.0	folP.l15.c4.ctg.1	2078	115.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1269	1271	AGC	189;189;189	A;G;C	151;160;155	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1682	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3831	131.4	1	SNP	p	S91F	1	.	.	271	273	TTC	692	694	TTC	123;123;123	T;T;C,A	102;98;101,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1682	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3831	131.4	1	SNP	p	D95G	1	.	.	283	285	GGC	704	706	GGC	120;120;121	G;G;C	97;98;93	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1682	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3831	131.4	1	SNP	p	G95N	0	.	.	283	285	GGC	704	706	GGC	120;120;121	G;G;C	97;98;93	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	756	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1697	132.9	1	SNP	p	G45D	0	.	.	133	135	GGC	608	610	GGC	205;206;204	G;G,A;C	169;169,1;172	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	448	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1285	104.2	0	.	n	.	0	A197.	DEL	197	197	A	717	717	A	203	A	169	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1618	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3367	143.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1614	1616	GTC	173;172;173	G;T;C	146;146;147	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1618	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3367	143.9	1	SNP	p	D86N	0	.	.	256	258	GAC	720	722	GAC	172;172;172	G;A;C	147;143;152	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1618	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3367	143.9	1	SNP	p	R87W	0	.	.	259	261	CGT	723	725	CGT	173;173;173	C;G;T,A	149;147;146,1	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1618	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3367	143.9	1	SNP	p	R87I	0	.	.	259	261	CGT	723	725	CGT	173;173;173	C;G;T,A	149;147;146,1	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1618	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3367	143.9	1	SNP	p	S87R	1	.	.	259	261	CGT	723	725	CGT	173;173;173	C;G;T,A	149;147;146,1	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1618	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3367	143.9	1	SNP	p	S88P	0	.	.	262	264	TCC	726	728	TCC	173;177;178	T;C;C	147;154;157	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1364	parE	1986	1986	99.95	parE.l6.c4.ctg.1	3059	133.3	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1549	1551	TGC	163;162;163	T;G;C	124;133;128	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1364	parE	1986	1986	99.95	parE.l6.c4.ctg.1	3059	133.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1759	1761	GGC	153;153;151	G;G;C	130;131;130	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	1244	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2706	137.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1448	1450	GCA	166;165;165	G,A;C;A	136,1;142;141	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1244	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2706	137.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1451	1453	ATC	165;165;166	A;T;C	143;140;144	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1244	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2706	137.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1463	1465	GTG	164;162;160	G,T;T;G,A	139,1;135;136,1	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1244	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2706	137.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1463	1465	GTG	164;162;160	G,T;T;G,A	139,1;135;136,1	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1244	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2706	137.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1967	1969	ACC	148;148;148	A;C,A;C	126;123,1;132	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1244	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2706	137.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2021	2023	GCG	149;148;147	G;C,G;G	124;112,1;119	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1244	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2706	137.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2021	2023	GCG	149;148;147	G;C,G;G	124;112,1;119	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1244	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2706	137.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2144	2146	GGC	162;162;162	G,C;G;C	131,1;133;131	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1244	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2706	137.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2153	2155	GGC	171;171;171	G,A;G,A;C	133,1;140,1;137	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1244	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2706	137.1	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2171	2173	TCG	174;177;177	T;C;G	133;143;140	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	1596	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3334	142.9	0	.	p	.	0	E418G	NONSYN	1252	1254	GAG	1783	1785	GGG	132;132;131	G;G,T;G,A	103;97,1;98,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	1596	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3334	142.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1792	1794	CCG	132;131;132	C;C;G	102;102;109	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	856	porA	1146	1146	99.56	porA.l6.c4.ctg.1	2189	116.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	731	731	C	144	C	119	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1157	1159	AAT	14;13;13	A;A;T	12;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1160	1162	AAT	13;13;13	A;A;T	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1184	1186	GCA	12;12;12	G;C;A	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1207	1209	GTA	11;11;11	G;T;A	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1213	1215	AAC	11;11;11	A;A;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1217	1221	TGGCG	11;11;11;11;11	T;G;G;C;G	10;10;10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1223	1225	GCT	11;11;11	G;C;T	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	1283	1285	TTA	9;9;9	T;T;A	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1328	1330	CAT	9;9;9	C;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1331	1333	AGT	9;9;9	A;G;T	7;6;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1429	20.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1340	1342	TAC	9;9;9	T;A;C	7;7;7	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	902	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1870	141.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	595	597	GAA	163;164;164	G,A;A;A	139,1;142;142	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	902	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1870	141.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	883	885	GAT	176;177;176	G,C;A;T,G	150,1;139;145,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	902	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1870	141.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1006	1008	TCA	175;174;174	T,A;C;A	141,1;148;147	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	902	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1870	141.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1135	1137	GTC	181;181;181	G,A;T,G;C	154,1;155,1;152	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	902	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1870	141.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1465	1467	GCA	194;195;197	G;C,A,G;A,T	166;166,1,1;162,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	902	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1870	141.1	1	SNP	p	G120K	1	.	.	358	360	AAG	841	843	AAG	172;173;173	A,G;A,G;G,T	142,1;146,1;144,2	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	902	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1870	141.1	1	SNP	p	D121N	0	.	.	361	363	GAC	844	846	GAC	173;174;174	G;A;C	144;143;144	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	902	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1870	141.1	1	SNP	p	A121D	1	.	.	361	363	GAC	844	846	GAC	173;174;174	G;A;C	144;143;144	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2906	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5283	164.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2270	2272	AAT	159;156;155	A;A;T	138;133;130	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	442	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1341	98.3	1	SNP	p	V57M	1	.	.	169	171	ATG	637	639	ATG	176;176;176	A;T;G	148;146;148	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
